Turtle Cameron
CIK: 0001758363•Chief Executive Officer
OfficerDirector
Primary company: BridgeBio Pharma, Inc. (BBIO)
Turtle Cameron is a corporate insider (Chief Executive Officer) at BridgeBio Pharma, Inc. (BBIO) filing SEC Form 4 transactions. 152 transactions across 4 companies, totaling $0 in purchases and $13,788,499 in sales. Source: SEC EDGAR.
Companies
Transaction History
Source: SEC EDGAR Form 4 insider transaction filings.
Company | Type | Shares | Price | Value | Shares After | Date | SEC |
|---|---|---|---|---|---|---|---|
| Sale | 590 | $88.91 | $52K | 582,540 | 7/1/2026 Filed: 7/1/2026 | Filing → | |
| Sale | 4,234 | $88.12 | $373K | 583,130 | 7/1/2026 Filed: 7/1/2026 | Filing → | |
| Sale | 10,176 | $87.44 | $890K | 587,364 | 7/1/2026 Filed: 7/1/2026 | Filing → | |
| Sale | 3,294 | $71.38 | $235K | 597,540 | 6/1/2026 Filed: 6/1/2026 | Filing → | |
| Sale | 8,149 | $70.50 | $575K | 600,834 | 6/1/2026 Filed: 6/1/2026 | Filing → | |
| Sale | 3,557 | $69.40 | $247K | 608,983 | 6/1/2026 Filed: 6/1/2026 | Filing → | |
| Sale | 300 | $74.96 | $22K | 612,540 | 5/1/2026 Filed: 5/1/2026 | Filing → | |
| Sale | 1,700 | $74.23 | $126K | 612,840 | 5/1/2026 Filed: 5/1/2026 | Filing → | |
| Sale | 3,100 | $73.14 | $227K | 614,540 | 5/1/2026 Filed: 5/1/2026 | Filing → | |
| Sale | 1,000 | $71.76 | $72K | 617,640 | 5/1/2026 Filed: 5/1/2026 | Filing → | |
| Sale | 3,600 | $70.77 | $255K | 618,640 | 5/1/2026 Filed: 5/1/2026 | Filing → | |
| Sale | 5,300 | $69.54 | $369K | 622,240 | 5/1/2026 Filed: 5/1/2026 | Filing → | |
| Sale | 2,656 | $49.92 | $133K | 627,540 | 4/1/2026 Filed: 4/1/2026 | Filing → | |
| Sale | 12,344 | $49.20 | $607K | 630,196 | 4/1/2026 Filed: 4/1/2026 | Filing → | |
Damora Therapeutics, Inc. DMRA | Award | 37,313 | $23.05 | $860K | 37,313 | 3/23/2026 Filed: 3/23/2026 | Filing → |
| Sale | 14,043 | $32.87 | $462K | 657,540 | 2/2/2026 Filed: 2/2/2026 | Filing → | |
| Sale | 957 | $31.82 | $30K | 671,583 | 2/2/2026 Filed: 2/2/2026 | Filing → | |
| Award | 528,000 | $30.61 | $16.16M | 528,000 | 1/9/2026 Filed: 1/9/2026 | Filing → | |
| Sale | 100 | $32.39 | $3K | 671,907 | 1/2/2026 Filed: 1/2/2026 | Filing → | |
| Sale | 2,191 | $31.79 | $70K | 672,007 | 1/2/2026 Filed: 1/2/2026 | Filing → |
Type
Sale
Shares
590
Price
$88.91
Value
$52K
Type
Sale
Shares
4,234
Price
$88.12
Value
$373K
Type
Sale
Shares
10,176
Price
$87.44
Value
$890K
Type
Sale
Shares
3,294
Price
$71.38
Value
$235K
Type
Sale
Shares
8,149
Price
$70.50
Value
$575K
Type
Sale
Shares
3,557
Price
$69.40
Value
$247K
Type
Sale
Shares
300
Price
$74.96
Value
$22K
Type
Sale
Shares
1,700
Price
$74.23
Value
$126K
Type
Sale
Shares
3,100
Price
$73.14
Value
$227K
Type
Sale
Shares
1,000
Price
$71.76
Value
$72K
Type
Sale
Shares
3,600
Price
$70.77
Value
$255K
Type
Sale
Shares
5,300
Price
$69.54
Value
$369K
Type
Sale
Shares
2,656
Price
$49.92
Value
$133K
Type
Sale
Shares
12,344
Price
$49.20
Value
$607K
Damora Therapeutics, Inc.
DMRA
Type
Award
Shares
37,313
Price
$23.05
Value
$860K
Type
Sale
Shares
14,043
Price
$32.87
Value
$462K
Type
Sale
Shares
957
Price
$31.82
Value
$30K
Type
Award
Shares
528,000
Price
$30.61
Value
$16.16M
Type
Sale
Shares
100
Price
$32.39
Value
$3K
Type
Sale
Shares
2,191
Price
$31.79
Value
$70K
AI Agent
Try asking...